DexCom, Inc. DXCM
79.32 USD -0.87 (-1.08%)
Regular-session close
78.18 -1.14 -1.44%
After hours · Nov 20, 7:54 PM ET
78.75 Day range 81.58
57.56 52-week range 92.34
- YTD
- +19.51%
- 1 year
- +35.78%
News
businesswire.com Dexcom Marks Athenry Opening With Celebration of Commercial Production Milestone ATHENRY, Ireland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in continuous glucose monitoring, today officially opened its state-of-the-art manufacturing facility in Athenry,…
marketbeat.com DexCom Sees Record New Patients in 2026 as Medicare Coverage Decision Looms DexCom NASDAQ: DXCM expects a record number of new patients in 2026 and is preparing for a potential expansion of Medicare coverage for continuous glucose monitoring, executives said during a…
benzinga.com Here's How Much $1000 Invested In DexCom 10 Years Ago Would Be Worth Today DexCom (NASDAQ:DXCM) has outperformed the market over the past 10 years by 3.92% on an annualized basis producing an average annual return of 16.67%. Currently, DexCom has a market capitalization of…
seekingalpha.com DexCom, Inc. (DXCM) Presents at Jefferies Global Healthcare Conference 2026 Transcript DexCom, Inc. (DXCM) Presents at Jefferies Global Healthcare Conference 2026 Transcript
defenseworld.net DexCom, Inc. $DXCM Shares Sold by Aberdeen Group plc Aberdeen Group plc cut its holdings in DexCom, Inc. (NASDAQ: DXCM) by 14.8% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The…
defenseworld.net Commonwealth Equity Services LLC Purchases 10,738 Shares of DexCom, Inc. $DXCM Commonwealth Equity Services LLC raised its position in DexCom, Inc. (NASDAQ: DXCM) by 18.0% during the third quarter, according to its most recent filing with the SEC. The firm owned 70,241 shares…benzinga.com Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $97 Canaccord Genuity analyst William Plovanic maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $90 to $97.
benzinga.com JP Morgan Maintains Neutral on DexCom, Raises Price Target to $85 JP Morgan analyst Robbie Marcus maintains DexCom (NASDAQ:DXCM) with a Neutral and raises the price target from $82 to $85.
benzinga.com Barclays Maintains Overweight on DexCom, Raises Price Target to $120 Barclays analyst Christopher Pasquale maintains DexCom (NASDAQ:DXCM) with a Overweight and raises the price target from $115 to $120.
benzinga.com StoneX Maintains Buy on DexCom, Raises Price Target to $93 StoneX analyst Bruce D. Jackson maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $82 to $93.
benzinga.com DexCom Q3 2026 Earnings Call Transcript DexCom (NASDAQ:DXCM) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…benzinga.com DexCom Raises FY2026 Sales Guidance from $5.180B-$5.250B to $5.200B-$5.250B vs $5.229B Est DexCom (NASDAQ:DXCM) raises FY2026 sales outlook from $5.180 billion-$5.250 billion to $5.200 billion-$5.250 billion vs $5.229 billion estimate.
benzinga.com DexCom Announces Availability Of Dexcom G7 15 Day Continuous Glucose Monitoring System In Canada From November DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) will be available in Canada beginning next…
benzinga.com Here’s How Much You Would Have Made Owning DexCom Stock In The Last 15 Years DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 13.07% on an annualized basis producing an average annual return of 26.01%. Currently, DexCom has a market capitalization of…finance.yahoo.com Quantinuum Inc. (QNT) Quantinuum’s third-quarter update showed record bookings of $98 million, higher revenue guidance, and major cash investment. Its Japan expansion with RIKEN and SoftBank advances quantum-AI ...
finance.yahoo.com Cerebras Systems Inc. (CBRS) Cerebras reported rapid cloud-led growth, new Microsoft business, and raised 2026 revenue guidance to $940 million–$960 million. Execution risks remain, including data-center delays, customer ...
247wallst.com Dexcom Inc Looking ahead to 2030, our model projects DXCM could trade at an average price of $143.38, with a potential range between $107.53 and $179.22. This represents a potential 80.8% return from today’s ...
